38 results on '"Adorni, M"'
Search Results
2. A systematic approach for the adequacy analysis of a set of experimental databases: Application in the framework of the ATRIUM activity
- Author
-
Baccou, J., Glantz, T., Ghione, A., Sargentini, L., Fillion, P., Damblin, G., Sueur, R., Iooss, B., Fang, J., Liu, J., Yang, C., Zheng, Y., Ui, A., Saito, M., Mendizábal Sanz, R., Bersano, A., Mascari, F., Skorek, T., Tiborcz, L., Hirose, Y., Takeda, T., Nakamura, H., Choi, C., Heo, J., Petruzzi, A., Zeng, K., Xie, Z., Wu, X., Eguchi, H., Pangukir, F., Breijder, P., Franssen, S., Perret, G., Clifford, I.D., Coscia, T.M., Di Maio, F., Zio, E., Pedroni, N., Zhang, J., Freixa, J., Rizzo, F., Ciurluini, C., Giannetti, F., and Adorni, M.
- Published
- 2024
- Full Text
- View/download PDF
3. Review of experimental database to support nuclear power plant safety analyses in SGTR and LOCA domains
- Author
-
Hózer, Z., Adorni, M., Arkoma, A., Busser, V., Bürger, B., Dieschbourg, K., Farkas, R., Girault, N., Herranz, L.E., Iglesias, R., Jobst, M., Kecek, A., Leclere, C., Lishchuk, R., Massone, M., Müllner, N., Sholomitsky, S., Slonszki, E., Szabó, P., Taurines, T., and Zimmerl, R.
- Published
- 2023
- Full Text
- View/download PDF
4. Current status of MELCOR 2.2 for fusion safety analyses
- Author
-
Mascari, F., Bersano, A., Adorni, M., D'Ovidio, G., Martín-Fuertes, F., Jin, X.Z., Mazzini, G., Gonfiotti, B., Georgiev, G., Leskovar, M., Bertani, C., Testoni, R., Giannetti, F., D'Onorio, M., Agnello, G., Di Maio, P.A., Angelucci, M., Paci, S., Grippo, G., Fernández-Cosials, K., Dongiovanni, D., and Malicki, M.
- Published
- 2023
- Full Text
- View/download PDF
5. CFD analysis of the erosion of a light gas stratification by means of a hot air jet in the MiniPanda facility
- Author
-
Attavino, A., Koloszar, L., Adorni, M., and Planquart, P.
- Published
- 2019
- Full Text
- View/download PDF
6. INTEGRATED PATHWAY ANALYSIS IDENTIFIES A 3-GENE SIGNATURE PREDICTING PLATINUM RESPONSE AND OUTCOME OF HIGH GRADE SEROUS OVARIAN CARCINOMA PATIENTS: EP1116
- Author
-
Bignotti, E, Benvenuto, G, Paracchini, L, Zanotti, L, Romani, C, Tognon, G, Calura, E, Vicini, D, Adorni, M, Paderno, M C, Bianchi, T, Odicino, F, Sartori, E, Ravaggi, A, DʼIncalci, M, Marchini, S, Todeschini, P, and Romualdi, C
- Published
- 2019
- Full Text
- View/download PDF
7. 263 Radiomics of the primary tumour as a tool to improve 18F-FDG-PET sensitivity in detecting nodal metastases in women with apparent early endometrial cancer
- Author
-
Buda, A, Crivellaro, C, Bernardi, E, Giuliani, D, Elisei, F, La Manna, M, Guerra, L, Delle Marchette, M, Grassi, T, Di Meo, ML, Adorni, M, Bellante, N, Landoni, C, and Fruscio, R
- Published
- 2019
- Full Text
- View/download PDF
8. 252 Comparison of two ultra-staging protocols for the detection of lymph node metastases in early stage cervical and endometrial cancer
- Author
-
Buda, A, Grassi, T, Lamanna, M, De ponti, E, Perego, P, Di Martino, G, Dell’Orto, F, Bazzurini, L, Magni, S, Adorni, M, Paderno, M, and Landoni, F
- Published
- 2019
- Full Text
- View/download PDF
9. 17 Standard ultrastaging (SU) compared to one-step nucleic acid amplification (OSNA) for sentinel lymph nodemetastasis detection in endometrial cancer patients: a retrospective large cohort comparison
- Author
-
Buda, A, Fanfani, F, Monterossi, G, Vecchione, F, La Fera, E, Adorni, M, Vicini, D, Gioé, A, Di Martino, G, De Ponti, E, Zannoni, GF, Perego, P, Landoni, F, and Scambia, G
- Published
- 2019
- Full Text
- View/download PDF
10. Sensitivity analysis of the MASLWR helical coil steam generator using TRACE
- Author
-
Mascari, F., Vella, G., Woods, B.G., Welter, K., Pottorf, J., Young, E., Adorni, M., and D’auria, F.
- Published
- 2011
- Full Text
- View/download PDF
11. Capabilities of TRANSURANUS code in simulating power ramp tests from the IFPE database
- Author
-
Rozzia, D., Adorni, M., Del Nevo, A., and D’Auria, F.
- Published
- 2011
- Full Text
- View/download PDF
12. STATINS INFLUENCE THE RELATIONSHIP BETWEEN ATP-BINDING CASSETTE TRANSPORTER A1 (ABCA1)-MEDIATED CHOLESTEROL EFFLUX AND CORONARY ATHEROSCLEROSIS IN RHEUMATOID ARTHRITIS.
- Author
-
Karpouzas, G., Papotti, B., Ormseth, S., Palumbo, M., Hernandez, E., Adorni, M. P., Zimetti, F., Budoff, M., and Ronda, N.
- Published
- 2023
- Full Text
- View/download PDF
13. 1.4 Manidipine Inhibits the Release of Interleukin-6 (Il-6) Induced by Modified Lipoprotein and by TNF-Alpha in Culture Human Endothelial Cells
- Author
-
Costa, S., Pedrelli, M., Ronda, N., Adorni, M., Bernini, F., and Cremonesi, G.
- Published
- 2008
- Full Text
- View/download PDF
14. INFLAMMATION AND IMMUNOMODULATORY THERAPIES INFLUENCE THE RELATIONSHIP BETWEEN ATP-BINDING CASSETTE TRANSPORTER A1 (ABCA1)-MEDIATED CHOLESTEROL EFFLUX AND CORONARY ATHEROSCLEROSIS IN RHEUMATOID ARTHRITIS.
- Author
-
Karpouzas, G., Papotti, B., Ormseth, S., Palumbo, M., Hernandez, E., Adorni, M. P., Zimetti, F., Budoff, M., and Ronda, N.
- Published
- 2023
- Full Text
- View/download PDF
15. ATP-BINDING CASSETTE G1 MEMBRANE TRANSPORTER-MEDIATED CHOLESTEROL EFFLUX CAPACITY INFLUENCES CORONARY ATHEROSCLEROSIS AND CARDIOVASCULAR RISK IN RHEUMATOID ARTHRITIS.
- Author
-
Karpouzas, G., Papotti, B., Ormseth, S., Palumbo, M., Hernandez, E., Adorni, M. P., Zimetti, F., Budoff, M., and Ronda, N.
- Published
- 2023
- Full Text
- View/download PDF
16. Distribution map of Ambrosia artemisiifolia L. (Asteraceae) in Italy.
- Author
-
Gentili, R., Gilardelli, F., Bona, E., Prosser, F., Selvaggi, A., Alessandrini, A., Martini, F., Nimis, P. L., Wilhalm, T., Adorni, M., Ardenghi, N. M. G., Barni, E., Bonafede, F., Bonini, M., Bouvet, D., Buffa, G., Ciappetta, S., Giordana, F., Faggi, G., and Ghiani, A.
- Subjects
AMBROSIA artemisiifolia ,PHYTOGEOGRAPHY ,RAGWEEDS ,DATA - Abstract
The spread of the invasive and allergenicAmbrosia artemisiifoliaL. in Italy was analysed and mapped using distribution data from a wide range of sources.Ambrosia artemisiifoliaoccupies 1057 floristic quadrants which are mostly distributed in the Po plain. The distribution obtained represents the basis to implement urgent management strategies. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
17. Validation of Advanced Computer Codes for VVER Technology: LB-LOCA Transient in PSB-VVER Facility.
- Author
-
Del Nevo, A., Adorni, M., D'Auria, F., Melikhov, O. I., Elkin, I. V., Schekoldin, V. I., Zakutaev, M. O., Zaitsev, S. I., and Benčík, M.
- Subjects
- *
LANGMUIR probes , *PRESSURIZED water reactors , *THERMAL hydraulics , *COMPARATIVE studies , *COOLANT loss in water cooled reactors , *HYDRAULIC transients ,DESIGN & construction - Abstract
The OECD/NEA PSB-VVER project provided unique and useful experimental data for code validation from PSB-VVER test facility. This facility represents the scaled-down layout of the Russian-designed pressurized water reactor, namely, VVER-1000. Five experiments were executed, dealing with loss of coolant scenarios (small, intermediate, and large break loss of coolant accidents), a primary-to-secondary leak, and a parametric study (natural circulation test) aimed at characterizing the VVER system at reduced mass inventory conditions. The comparative analysis, presented in the paper, regards the large break loss of coolant accident experiment. Four participants from three different institutions were involved in the benchmark and applied their own models and set up for four different thermal-hydraulic system codes. The benchmark demonstrated the performances of such codes in predicting phenomena relevant for safety on the basis of fixed criteria. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
18. W10-O-003 Pitavastatin differently modulates ABCAI-mediated lipid efflux in macrophages and hepatic cells
- Author
-
Zanotti, I., Favari, E., Adorni, M., Zimetti, F., and Bernini, F.
- Published
- 2005
- Full Text
- View/download PDF
19. Engineering spatial concepts.
- Author
-
Micucci, D., Tisato, F., and Adorni, M.
- Subjects
ENGINEERING ,COMPUTER software ,ONTOLOGY ,COMPONENT software ,OPERATIONAL definitions - Abstract
The success of a software system strongly depends on the ability of turning a precise domain analysis into a concrete architecture. Even if the domain model relies on sound ontological bases, there is often a wide semantic gap between the conceptual model and the concrete components that should reify it. To fill the semantic gap, relevant domain concepts should be engineered by identifying the corresponding architectural abstractions, which can be realized by concrete software components. Space plays a crucial role in many application domains, but surprisingly, related architectural abstractions have not emerged yet. This paper proposes space-related abstractions derived from the application of classical software engineering principles; in particular, the information hiding principle that leads to an operational definition of space. Basic abstractions are refined to deal with architectural aspects. As the underlying software engineering principles are close to principles that underlie the definition of space ontologies, the conjecture is that the proposed space architectural abstractions might be the basis for a formalization in ontological terms. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
20. Guest editorial preface: Software and system engineering: an ontological perspective.
- Author
-
Micucci, D., Sartori, F., and Adorni, M.
- Subjects
INFORMATION resources management ,COMPUTER software development - Abstract
The article discusses various reports published within the issue, including one on the clarification of the model used in the area of Information Systems by Jose Maria Cavero and Esperanza Marcos, another one on the efficiency of Software Measurement Ontology by Felix Garcia, and the use of function-behaviour-structure (FBS) in designing the software management field by Udo Kannengiesser.
- Published
- 2009
- Full Text
- View/download PDF
21. Neoadjuvant chemotherapy followed by radical surgery in locally advanced vulvar carcinoma: a single-institution experience.
- Author
-
Adorni M, Bazzurini L, Lissoni AA, Vecchione F, Negri S, Grassi T, Buda A, and Landoni F
- Subjects
- Aged, Antineoplastic Combined Chemotherapy Protocols adverse effects, Chemotherapy, Adjuvant, Female, Humans, Ifosfamide, Neoadjuvant Therapy, Neoplasm Staging, Paclitaxel, Platinum, Retrospective Studies, Uterine Cervical Neoplasms pathology, Vulvar Neoplasms drug therapy, Vulvar Neoplasms surgery
- Abstract
Background: Squamous cell carcinoma of the vulva is a rare malignancy that affects elderly women. About one-third of vulvar cancers are diagnosed in an advanced stage, requiring extensive surgery. Neoadjuvant chemotherapy (NACT) has been introduced to reduce local tumor burden. In this retrospective study, we analyze the efficacy and toxicity of NACT followed by radical surgery., Methods: Patients with locally advanced vulvar cancer (LAVC) treated at our institution with neoadjuvant platinum and paclitaxel-based chemotherapy ± ifosfamide followed by surgery at our institution were retrospectively identified., Results: Fourteen patients (93%) completed NACT with tolerable toxicities (G3-G4 toxicity: 30%). Thirteen patients (87%) underwent surgery. The overall clinical response rate on vulvar disease was 66% (20% complete response, 46% partial response), confirmed by histopathologic analysis, while on inguinal lymph nodes it was 69% (23% complete response, 46% partial response). At the pathologic examination, all patients had negative surgical margins. Three out of 9 patients (33%) with lesions infiltrating the urethral meatus and 4 patients out of 7 (57%) with anal involvement did not require urethral amputation or colostomy, respectively, after NACT. No severe postoperative complications were described. Overall survival at 5 years was 60%, and median overall survival was 76 months., Conclusion: NACT followed by surgery in locally advanced vulvar cancer is well tolerated and allows surgical modulation.
- Published
- 2022
- Full Text
- View/download PDF
22. Advanced low grade serous ovarian cancer: A retrospective analysis of surgical and chemotherapeutic management in two high volume oncological centers.
- Author
-
Di Lorenzo P, Conteduca V, Scarpi E, Adorni M, Multinu F, Garbi A, Betella I, Grassi T, Bianchi T, Di Martino G, Amadori A, Maniglio P, Strada I, Carinelli S, Jaconi M, Aletti G, Zanagnolo V, Maggioni A, Savelli L, De Giorgi U, Landoni F, Colombo N, and Fruscio R
- Abstract
Simple Summary: Low-grade serous ovarian cancer (LGSOC) represents an uncommon histotype of serous ovarian cancer (accounting for approximately 5% of all ovarian cancer) with a distinct behavior compared to its high-grade serous counterpart, characterized by a better prognosis and low response rate to chemotherapeutic agents. Similar to high-grade serous ovarian cancer, cytoreductive surgery is considered crucial for patient survival. This retrospective study aimed to analyze the outcomes of women affected by advanced stages (III-IV FIGO) of LGSOC from two high-volume oncological centers for ovarian neoplasm. In particular, we sought to evaluate the impact on survival outcomes of optimal cytoreductive surgery [i.e., residual disease (RD) <10 mm at the end of surgery]. The results of our work confirm the role of complete cytoreduction (i.e., no evidence of disease after surgery) in the survival of patients and even the positive prognostic role of a minimal RD (i.e., <10 mm), whenever complete cytoreduction cannot be achieved., Background: Low-grade serous ovarian cancer (LGSOC) is a rare entity with different behavior compared to high-grade serous (HGSOC). Because of its general low chemosensitivity, complete cytoreductive surgery with no residual disease is crucial in advanced stage LGSOC. We evaluated the impact of optimal cytoreduction on survival outcome both at first diagnosis and at recurrence., Methods: We retrospectively studied consecutive patients diagnosed with advanced LGSOCs who underwent cytoreductive surgery in two oncological centers from January 1994 to December 2018. Survival curves were estimated by the Kaplan-Meier method, and 95% confidence intervals (95% CI) were estimated using the Greenwood formula., Results: A total of 92 patients were included (median age was 47 years, IQR 35-64). The median overall survival (OS) was 142.3 months in patients with no residual disease (RD), 86.4 months for RD 1-10 mm and 35.2 months for RD >10 mm (p = 0.002). Progression-free survival (PFS) was inversely related to RD after primary cytoreductive surgery (RD = 0 vs RD = 1-10 mm vs RD >10 mm, p = 0.002). On multivariate analysis, RD 1-10 mm (HR = 2.30, 95% CI 1.30-4.06, p = 0.004), RD >10 mm (HR = 3.89, 95% CI 1.92-7.88, p = 0.0004), FIGO stage IV (p = 0.001), and neoadjuvant chemotherapy (NACT) (p = 0.010) were independent predictors of PFS. RD >10 mm (HR = 3.13, 95% CI 1.52-6.46, p = 0.004), FIGO stage IV (p <0.0001) and NACT (p = 0.030) were significantly associated with a lower OS., Conclusions: Optimal cytoreductive surgery improves survival outcomes in advanced stage LGSOC s . When complete debulking is impossible, a RD <10 mm confers better OS compared to an RD >10 mm in this setting of patients., Competing Interests: NC: Consultancy and advisory board participation: Roche; PharmaMar; Astra-Zeneca; Clovis Oncology; MSD; GlaxoSmithKline; Tesaro; Pfizer; BIOCAD; Immunogen; Mersana; Eisai; Oncxerna. Speakers for AstraZeneca, Tesaro, Novartis, Clovis, MSD, GlaxoSmithKline, Eisai. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Di Lorenzo, Conteduca, Scarpi, Adorni, Multinu, Garbi, Betella, Grassi, Bianchi, Di Martino, Amadori, Maniglio, Strada, Carinelli, Jaconi, Aletti, Zanagnolo, Maggioni, Savelli, De Giorgi, Landoni, Colombo and Fruscio.)
- Published
- 2022
- Full Text
- View/download PDF
23. The impact of low-volume metastasis on disease-free survival of women with early-stage cervical cancer.
- Author
-
Buda A, Casarin J, Mueller M, Fanfani F, Zapardiel I, Mereu L, Puppo A, De Ponti E, Adorni M, Ferrari D, Gasparri ML, Ghezzi F, Scambia G, and Papadia A
- Subjects
- Adenocarcinoma diagnosis, Adenocarcinoma pathology, Adenocarcinoma therapy, Adult, Carcinoma, Adenosquamous diagnosis, Carcinoma, Adenosquamous pathology, Carcinoma, Adenosquamous therapy, Carcinoma, Squamous Cell diagnosis, Carcinoma, Squamous Cell pathology, Carcinoma, Squamous Cell therapy, Case-Control Studies, Disease-Free Survival, Female, Humans, Lymph Nodes pathology, Lymphatic Metastasis, Middle Aged, Neoplasm Micrometastasis therapy, Neoplasm Staging, Prognosis, Retrospective Studies, Sentinel Lymph Node Biopsy, Tumor Burden, Uterine Cervical Neoplasms diagnosis, Neoplasm Micrometastasis diagnosis, Uterine Cervical Neoplasms pathology, Uterine Cervical Neoplasms therapy
- Abstract
Purpose: We aimed to assess the impact of low-volume metastasis (micrometastasis and isolated tumor cells) on disease-free survival (DFS) of women with early-stage cervical cancer., Methods: Women with clinically suspected stage 1A-IB2 (FIGO 2018 classification) disease who underwent retroperitoneal nodal staging between October 2010 and April 2018, were retrospectively analyzed. The group of women who had undergone lymphadenectomy and standard node pathologic analysis (H&E group), were compared to the group undergoing sentinel node mapping (SLN) and ultrastaging with or without lymphadenectomy (ultrastaging group). At a median follow-up of 45 months, the DFS curves were analyzed., Results: Overall, 573 patients were revised (272 in the H&E group and 302 in the ultrastaging group). Eighty-five patients presented lymph node metastasis (32 in H&E, 53 in ultrastaging). Ultrastaging protocol increased the rate of low-volume metastasis by 5.6%. Twenty patients showed exclusive micrometastasis or ITC's. Seventy-three recurrences occurred (35 in H&E, 38 in ultrastaging). Only 1 out of 53 patients in the ultrastaging group (1.9%) presented with micrometastasis recurred. The 3-year disease-free survival was 89% for the H&E group, and 88% for the ultrastaging group, respectively (p = 0.175)., Conclusion: Ultrastaging analysis allowed increasing the detection of low volume metastasis in women with early-stage cervical cancer. However, the type of nodal staging did not have an impact on patients' 3-year disease-free survival.
- Published
- 2021
- Full Text
- View/download PDF
24. Correction to: The impact of low-volume metastasis on disease-free survival of women with early-stage cervical cancer.
- Author
-
Buda A, Casarin J, Mueller M, Fanfani F, Zapardiel I, Mereu L, Puppo A, De Ponti E, Adorni M, Ferrari D, Gasparri ML, Ghezzi F, Scambia G, and Papadia A
- Published
- 2021
- Full Text
- View/download PDF
25. Genome-wide Copy-number Alterations in Circulating Tumor DNA as a Novel Biomarker for Patients with High-grade Serous Ovarian Cancer.
- Author
-
Paracchini L, Beltrame L, Grassi T, Inglesi A, Fruscio R, Landoni F, Ippolito D, Delle Marchette M, Paderno M, Adorni M, Jaconi M, Romualdi C, D'Incalci M, Siravegna G, and Marchini S
- Subjects
- Adult, Aged, Aged, 80 and over, Combined Modality Therapy, Cystadenocarcinoma, Serous blood, Cystadenocarcinoma, Serous therapy, Diagnostic Imaging, Female, Genome-Wide Association Study, Humans, Liquid Biopsy methods, Middle Aged, Neoplasm Grading, Neoplasm Staging, Ovarian Neoplasms blood, Ovarian Neoplasms therapy, Sensitivity and Specificity, Treatment Outcome, Young Adult, Biomarkers, Tumor, Circulating Tumor DNA, Cystadenocarcinoma, Serous diagnosis, Cystadenocarcinoma, Serous genetics, DNA Copy Number Variations, Ovarian Neoplasms diagnosis, Ovarian Neoplasms genetics
- Abstract
Purpose: High-grade serous epithelial ovarian cancer (HGS-EOC) is defined by high levels of somatic copy-number alterations (SCNA) with marked spatial and temporal tumor heterogeneity. Biomarkers serving to monitor drug response and detect disease recurrence are lacking, a fact which reflects an unmet clinical need., Experimental Design: A total of 185 plasma samples and 109 matched tumor biopsies were collected from 46 patients with HGS-EOC, and analyzed by shallow whole-genome sequencing (sWGS). The percentage of tumor fraction (TF) in the plasma was used to study the biological features of the disease at the time of diagnosis (T0) and correlated with patients' survival. Longitudinal analysis of TF was correlated with CA-125 levels and radiological images to monitor disease recurrence., Results: Gain in the clonal regions, 3q26.2 and 8q24.3 , was observed in the 87.8% and 78.05% of plasma samples, suggesting that plasma sWGS mirrors solid biopsies. At T0, multivariate analysis revealed that plasma TF levels were an independent prognostic marker of relapse ( P < 0.022). After platinum (Pt)-based treatment, circulating tumor DNA (ctDNA) analysis showed a change in the heterogeneous pattern of genomic amplification, including an increased frequency of amplification, compared with before Pt-based treatment in the 19p31.11 and 19q13.42 regions. TF in serially collected ctDNA samples outperformed CA-125 in anticipating clinical and radiological progression by 240 days (range, 37-491)., Conclusions: Our results support the notion that sWGS is an inexpensive and useful tool for the genomic analysis of ctDNA in patients with HGS-EOC to monitor disease evolution and to anticipate relapse better than serum CA-125, the routinely used clinical biomarker. See related commentary by Dhani, p. 2372 ., (©2020 American Association for Cancer Research.)
- Published
- 2021
- Full Text
- View/download PDF
26. Early-stage clear cell ovarian cancer compared to high-grade histological subtypes: An outcome exploratory analysis in two oncology centers.
- Author
-
Ceppi L, Grassi T, Galli F, Buda A, Aletti G, Lissoni AA, Adorni M, Garbi A, Colombo N, Bonazzi C, Landoni F, and Fruscio R
- Subjects
- Adenocarcinoma, Clear Cell drug therapy, Adenocarcinoma, Clear Cell mortality, Adenocarcinoma, Clear Cell surgery, Adult, Carcinoma, Endometrioid drug therapy, Carcinoma, Endometrioid mortality, Carcinoma, Endometrioid pathology, Carcinoma, Endometrioid surgery, Chemotherapy, Adjuvant, Cystadenocarcinoma, Serous drug therapy, Cystadenocarcinoma, Serous mortality, Cystadenocarcinoma, Serous pathology, Cystadenocarcinoma, Serous surgery, Disease-Free Survival, Female, Humans, Italy epidemiology, Middle Aged, Neoplasm Grading, Neoplasm Staging, Ovarian Neoplasms drug therapy, Ovarian Neoplasms mortality, Ovarian Neoplasms surgery, Prognosis, Treatment Outcome, Adenocarcinoma, Clear Cell pathology, Ovarian Neoplasms pathology
- Abstract
Objective: advanced stage clear cell ovarian cancer (CCOC) carries a higher risk of relapse and death compared to other histological subtypes. The prognosis of early-stage CCOC is controversial., Methods: Early-stage high-grade OC patients from two Italian oncologic centers were included. Patients with early-stage CCOC were compared with those with high-grade endometrioid (HGE) and serous (HGS) OC in terms of relapse-free interval (RFI), cancer-specific survival (CSS) and post relapse cancer-specific survival (prCSS). The Cox proportional hazard model and the restricted mean survival time were used., Results: Between 1981 and 2012, 134 patients with CC, 152 with HGE and 160 with HGS were treated at two referral centers. Median follow-up was 11.5 years. Ten years RFI rates were 80.6%, 72.1%, 60.6%, and CSS rates were 84.3%, 82.6%, 81.7% respectively. Adjuvant chemotherapy significantly improved RFI (aHR 0.61, 95%CI 0.40 to 0.91, P = 0.015). In the multivariable analysis HGS histotype was associated with a shorter RFI compared to CC, (Hazard Ratio [HR]: 1.81; 95%CI: 1.12-2.93; P = 0.016), whereas CSS was not statistically different. prCSS was longer in HGS compared to CCOC (HR, 0.36; 95% CI, 0.17-0.74; P = 0.006). According to the stage, IA/IB/IC1 HGSOC had a shorter RFI (HR, 2.13; 95% CI, 1.14-3.99; P = 0.018) compared to IA/IB/IC1 CCOC, but similar CSS. For prCSS, CC compared to HGS conferred a worse prognosis regardless of the initial stage., Conclusions: Early-stage CCOC is associated with a longer RFI, similar CSS and a shorter prCSS compared to HGSOC. No prognostic differences were observed between CC and HGE OC. The relapse risk was the lowest in IA/IB/IC1 CC compared to HGS, whereas CC displayed poor sensitivity to chemotherapy after relapse., Competing Interests: Declaration of Competing Interest Dr. Colombo reports personal fees from Roche, Pharmamar, Astra Zeneca, Clovis, Tesaro, GSK, Pfizer, Amgen, Immunogen, MSD, Advaxis, Takeda, Novartis, Elipses and Biocad, outside the submitted work. The authors report no other conflicts of interest in this work., (Copyright © 2020 Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
27. Impact of invasive alien plants on native plant communities and Natura 2000 habitats: State of the art, gap analysis and perspectives in Italy.
- Author
-
Lazzaro L, Bolpagni R, Buffa G, Gentili R, Lonati M, Stinca A, Acosta ATR, Adorni M, Aleffi M, Allegrezza M, Angiolini C, Assini S, Bagella S, Bonari G, Bovio M, Bracco F, Brundu G, Caccianiga M, Carnevali L, Di Cecco V, Ceschin S, Ciaschetti G, Cogoni A, Foggi B, Frattaroli AR, Genovesi P, Gigante D, Lucchese F, Mainetti A, Mariotti M, Minissale P, Paura B, Pellizzari M, Perrino EV, Pirone G, Poggio L, Poldini L, Poponessi S, Prisco I, Prosser F, Puglisi M, Rosati L, Selvaggi A, Sottovia L, Spampinato G, Stanisci A, Venanzoni R, Viciani D, Vidali M, Villani M, and Lastrucci L
- Subjects
- Biodiversity, Italy, Plants, Ecosystem, Introduced Species
- Abstract
Invasive alien plants are a major threat to biodiversity and they contribute to the unfavourable conservation status of habitats of interest to the European Community. In order to favour implementation of European Union Regulation no. 1143/2014 on invasive alien species, the Italian Society of Vegetation Science carried out a large survey led by a task force of 49 contributors with expertise in vegetation across all the Italian administrative regions. The survey summed up the knowledge on impact mechanisms of invasive alien plants in Italy and their outcomes on plant communities and the EU habitats of Community Interest, in accordance with Directive no. 92/43/EEC. The survey covered 241 alien plant species reported as having deleterious ecological impacts. The data collected illustrate the current state of the art, highlight the main gaps in knowledge, and suggest topics to be further investigated. In particular, the survey underlined competition as being the main mechanism of ecological impact on plant communities and Natura 2000 habitats. Of the 241 species, only Ailanthus altissima was found to exert an ecological impact on plant communities and Natura 2000 habitats in all Italian regions; while a further 20 species impact up to ten out of the 20 Italian administrative regions. Our data indicate that 84 out of 132 Natura 2000 Habitats (64%) are subjected to some degree of impact by invasive alien plants. Freshwater habitats and natural and semi-natural grassland formations were impacted by the highest number of alien species, followed by coastal sand dunes and inland dunes, and forests. Although not exhaustive, this research is the first example of nationwide evaluation of the ecological impacts of invasive alien plants on plant communities and Natura 2000 Habitats., (Copyright © 2020 Elsevier Ltd. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
28. Expression profiles of PRKG1, SDF2L1 and PPP1R12A are predictive and prognostic factors for therapy response and survival in high-grade serous ovarian cancer.
- Author
-
Benvenuto G, Todeschini P, Paracchini L, Calura E, Fruscio R, Romani C, Beltrame L, Martini P, Ravaggi A, Ceppi L, Sales G, Donati F, Perego P, Zanotti L, Ballabio S, Grassi T, Delle Marchette M, Tognon G, Sartori E, Adorni M, Odicino F, D'Incalci M, Bignotti E, Romualdi C, and Marchini S
- Subjects
- Adult, Aged, Cystadenocarcinoma, Serous genetics, Cystadenocarcinoma, Serous pathology, Female, Gene Expression Regulation, Neoplastic, Humans, Middle Aged, Neoplasm Grading, Ovarian Neoplasms genetics, Ovarian Neoplasms pathology, Prognosis, Retrospective Studies, Survival Analysis, Treatment Outcome, Cyclic GMP-Dependent Protein Kinase Type I genetics, Cystadenocarcinoma, Serous drug therapy, Gene Expression Profiling methods, Membrane Proteins genetics, Myosin-Light-Chain Phosphatase genetics, Ovarian Neoplasms drug therapy, Platinum therapeutic use
- Abstract
High-grade serous ovarian cancer (HGS-EOCs) is generally sensitive to front-line platinum (Pt)-based chemotherapy although most patients at an advanced stage relapse with progressive resistant disease. Clinical or molecular data to identify primary resistant cases at diagnosis are not yet available. HGS-EOC biopsies from 105 Pt-sensitive (Pt-s) and 89 Pt-resistant (Pt-r) patients were retrospectively selected from two independent tumor tissue collections. Pathway analysis was done integrating miRNA and mRNA expression profiles. Signatures were further validated in silico on a cohort of 838 HGS-EOC cases from a published dataset. In all, 131 mRNAs and 5 miRNAs belonging to different functionally related molecular pathways distinguish Pt-s from Pt-r cases. Then, 17 out of 23 selected elements were validated by orthogonal approaches (SI signature). As resistance to Pt is associated with a short progression-free survival (PFS) and overall survival (OS), the prognostic role of the SI signature was assessed, and 14 genes associated with PFS and OS, in multivariate analyses (SII signature). The prognostic value of the SII signature was validated in a third extensive cohort. The expression profiles of SDF2L1, PPP1R12A and PRKG1 genes (SIII signature) served as independent prognostic biomarkers of Pt-response and survival. The study identified a prognostic molecular signature based on the combined expression profile of three genes which had never been associated with the clinical outcome of HGS-EOC. This may lead to early identification, at the time of diagnosis, of patients who would not greatly benefit from standard chemotherapy and are thus eligible for novel investigational approaches., (© 2020 UICC.)
- Published
- 2020
- Full Text
- View/download PDF
29. Detection of TP53 Clonal Variants in Papanicolaou Test Samples Collected up to 6 Years Prior to High-Grade Serous Epithelial Ovarian Cancer Diagnosis.
- Author
-
Paracchini L, Pesenti C, Delle Marchette M, Beltrame L, Bianchi T, Grassi T, Buda A, Landoni F, Ceppi L, Bosetti C, Paderno M, Adorni M, Vicini D, Perego P, Leone BE, D'Incalci M, Marchini S, and Fruscio R
- Subjects
- Female, Humans, Mass Screening methods, Mass Screening statistics & numerical data, Middle Aged, Sensitivity and Specificity, Time Factors, Carcinoma, Ovarian Epithelial metabolism, Carcinoma, Ovarian Epithelial pathology, Clone Cells pathology, Cystadenocarcinoma, Serous metabolism, Cystadenocarcinoma, Serous pathology, Early Detection of Cancer methods, Ovarian Neoplasms metabolism, Ovarian Neoplasms pathology, Papanicolaou Test methods, Papanicolaou Test statistics & numerical data, Tumor Suppressor Protein p53 analysis
- Abstract
Importance: The low 5-year survival rate of women with high-grade serous epithelial ovarian cancer (HGS-EOC) is related to its late diagnosis; thus, improvement in diagnosis constitutes a crucial step to increase the curability of this disease., Objective: To determine whether the presence of the clonal pathogenic TP53 variant detected in matched primary tumor biopsies can be identified in DNA purified from Papanicolaou test samples collected from women with HGS-EOC years before the diagnosis., Design, Setting, and Participants: This cohort study was conducted among a single-center cohort of women with histologically confirmed diagnosis of HGS-EOC recruited at San Gerardo Hospital, Monza, Italy, from October 15, 2015, to January 4, 2019. Serial dilutions of DNA derived from tumor samples and DNA extracted from healthy women's Papanicolaou test samples were analyzed to define the sensitivity and specificity of droplet digital polymerase chain reaction assays designed to detect the TP53 variants identified in tumors. All available brush-based Papanicolaou test slides performed up to 6 years before diagnosis were investigated at the Mario Negri Institute, Milano, Italy. Data were analyzed from October 2018 to December 2019., Main Outcomes and Measures: The presence of tumor pathogenic TP53 variants was assessed by the droplet digital polymerase chain reaction approach in DNA purified from Papanicolaou test samples obtained from the same patients before diagnosis during cervical cancer screenings., Results: Among 17 included patients (median [interquartile range] age at diagnosis, 60 [53-69] years), Papanicolaou tests withdrawn before diagnosis presented tumor-matched TP53 variants in 11 patients (64%). In 2 patients for whom longitudinal Papanicolaou tests were available, including 1 patient with Papanicolaou tests from 25 and 49 months before diagnosis and 1 patient with Papanicolaou tests from 27 and 68 months before diagnosis, the TP53 clonal variant was detected at all time points., Conclusions and Relevance: These findings suggest that noninvasive early molecular diagnosis of HGS-EOC is potentially achievable through detection of TP53 clonal variants in the DNA purified from Papanicolaou tests performed during cervical cancer screening.
- Published
- 2020
- Full Text
- View/download PDF
30. Impact of Bevacizumab-containing Primary Treatment on Outcome of Recurrent Ovarian Cancer: An Italian Study.
- Author
-
Gadducci A, Cosio S, Lissoni AA, Zizioli V, Adorni M, Ferrero AM, Landoni F, and Sartori E
- Subjects
- Adult, Aged, Bevacizumab administration & dosage, Carboplatin, Carcinoma, Ovarian Epithelial mortality, Carcinoma, Ovarian Epithelial pathology, Cytoreduction Surgical Procedures, Female, Humans, Italy epidemiology, Middle Aged, Neoplasm Recurrence, Local mortality, Neoplasm Recurrence, Local pathology, Neoplasm Staging, Ovarian Neoplasms mortality, Ovarian Neoplasms pathology, Paclitaxel, Retrospective Studies, Survival Rate, Treatment Outcome, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Carcinoma, Ovarian Epithelial drug therapy, Neoplasm Recurrence, Local drug therapy, Ovarian Neoplasms drug therapy
- Abstract
Background/aim: The aim of the study was to assess the outcome of advanced ovarian cancer patients who i) underwent primary surgery followed by carboplatin/paclitaxel-based chemotherapy with or without bevacizumab, ii) were in complete response after chemotherapy, iii) and subsequently recurred., Patients and Methods: The hospital records of 138 complete responders after chemotherapy with (n=58) or without (n=80) bevacizumab were reviewed., Results: Both survival after recurrence and overall survival were related to age (≤61 vs. >61 years, p=0.002 and p=0.0001), performance status (0 vs. ≥1, p=0.002 and p=0.001), histotype (serous vs. non serous, p=0.005 and p=0.01), time to recurrence (≥12 vs. <12 months, p<0.0001 and p<0.0001) and treatment at recurrence (surgery plus chemotherapy vs. chemotherapy, p=0.01 and p=0.004), but not to first-line treatment., Conclusion: This investigation failed to detect a more aggressive behavior of recurrent ovarian cancer after bevacizumab-containing primary treatment., (Copyright© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
31. Role of 18 F-fluoro-2-deoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) in malignant ovarian germ cell tumors: a single-center experience with long term follow-up.
- Author
-
Dolci C, Ceppi L, Guerra L, Crivellaro C, Lamanna M, Adorni M, Elisei F, Bonazzi CM, Sina F, Fruscio R, and Messa C
- Subjects
- Adult, Female, Follow-Up Studies, Humans, Middle Aged, Positron Emission Tomography Computed Tomography methods, Retrospective Studies, Young Adult, Fluorodeoxyglucose F18, Neoplasms, Germ Cell and Embryonal diagnostic imaging, Ovarian Neoplasms diagnostic imaging, Radiopharmaceuticals
- Abstract
Introduction:
18 F-fluoro-2-deoxyglucose positron emission tomography/computed tomography (18 F-FDG PET/CT) is a diagnostic tool widely used in oncology, but to date there are no established recommendations for its use in malignant ovarian germ cell tumors. The aim of this study was to evaluate the role of18 F-FDG PET/CT in the clinical management of patients with malignant ovarian germ cell tumors., Methods: This was a retrospective review of18 F-FDG PET/CT scans performed in patients diagnosed with malignant ovarian germ cell tumors treated at the gynecology department of San Gerardo Hospital (Monza, Italy) from June 2006 to December 2016. Data collected included clinical history, radiological, biochemical and pathological evaluation, treatment, follow-up, outcome, and clinical indication for the PET/CT scan. PET/CT findings were categorized as negative/normal (no abnormal FDG uptake or physiological uptake), positive/abnormal (FDG uptake considered to indicate active germ cell malignancy), or equivocal (FDG uptake of uncertain significance, not clearly correlated to neoplastic disease)., Results: A total of 69 PET/CT scans in 37 patients were evaluated. The mean age at diagnosis was 25 years (range 20-48). The majority of patients had International Federation of Gynecology and Obstetrics (FIGO) stage I (22/37) disease and had a diagnosis of dysgerminomas (18/37). Imaging indications were initial staging before treatment (4/69, 6%), staging after inadequate staging surgery (24/69, 35%), restaging after adjuvant chemotherapy (17/69, 25%), relapse suspect (9/69, 13%), and follow-up (15/69, 21%). Pathology confirmation of PET/CT results was available in 28/69 (40.5%) studies. All negative PET/CT (15/28) cases were confirmed with laparoscopy as true negative; among 13/28 positive PET cases, histopathology confirmed 7 (54%) as true positive and 6 (46%) as false positive (5 inflammatory and 1 mature teratoma implants). Patient-based analysis showed 100% sensitivity, 71% specificity, 54% positive predictive value, 100% negative predictive value, and 79% accuracy. Clinical follow-up was available in 41 (59.4%) of 69 PET/CT images: 28/41 studies were negative and 13/41 positive. A mean follow-up of 28 months (median 15, range 5-102) confirmed negative PET/CT studies. A total of 13 positive PET/CT patients underwent chemotherapy with subsequent evidence of disease response., Discussion: PET/CT in malignant ovarian germ cell tumors was mainly performed for staging after inadequate staging surgery or for restaging after adjuvant chemotherapy. PET/CT was associated with high sensitivity and negative predictive value., Competing Interests: Competing interests: None declared., (© IGCS and ESGO 2019. No commercial re-use. See rights and permissions. Published by BMJ.)- Published
- 2019
- Full Text
- View/download PDF
32. Vitamin D replacement ameliorates serum lipoprotein functions, adipokine profile and subclinical atherosclerosis in pre-menopausal women.
- Author
-
Greco D, Kocyigit D, Adorni MP, Marchi C, Ronda N, Bernini F, Gurses KM, Canpinar H, Guc D, Oguz SH, Gurlek A, Strazzella A, Simonelli S, Tokgozoglu L, and Zimetti F
- Subjects
- ATP Binding Cassette Transporter 1 metabolism, Adult, Asymptomatic Diseases, Atherosclerosis blood, Atherosclerosis diagnosis, Atherosclerosis etiology, Biomarkers blood, Cholecalciferol adverse effects, Female, Humans, Proof of Concept Study, Resistin blood, Time Factors, Treatment Outcome, Turkey, Vitamin D analogs & derivatives, Vitamin D blood, Vitamin D Deficiency blood, Vitamin D Deficiency complications, Vitamin D Deficiency diagnosis, Adipokines blood, Atherosclerosis prevention & control, Cholecalciferol administration & dosage, Cholesterol, HDL blood, Dietary Supplements adverse effects, High-Density Lipoproteins, Pre-beta blood, Premenopause blood, Vitamin D Deficiency drug therapy
- Abstract
Background and Aims: Low vitamin D (vitD) has been linked to increased cardiovascular (CV) risk, but the effects of vitD supplementation are not clarified. We evaluated the impact of vitD normalization on HDL cholesterol efflux capacity (CEC), which inversely correlates with CV risk, the proatherogenic serum cholesterol loading capacity (CLC), adipokine profile and subclinical atherosclerosis., Methods and Results: Healthy premenopausal women with vitD deficiency (n = 31) underwent supplementation. Subclinical atherosclerosis was evaluated by flow-mediated dilation (FMD), pulse wave velocity (PWV) and augmentation index (AIx), measured with standard techniques. HDL CEC and serum CLC were measured by a radioisotopic and fluorimetric assay, respectively. Malondialdehyde (MDA) in HDL was quantified by the TBARS assay. Pre-β HDL was assessed by 2D-electrophoresis. Serum adipokines were measured by ELISA. VitD replacement restored normal levels of serum 25-hydroxyvitamin D (25OHD) and significantly improved FMD (+4%; p < 0.001), PWV (-4.1%: p < 0.001) and AIx (-16.1%; p < 0.001). Total CEC was significantly improved (+19.5%; p = 0.003), with a specific increase in the ABCA1-mediated CEC (+70.8%; p < 0.001). HDL-MDA slightly but significantly decreased (-9.6%; p = 0.027), while no difference was detected in pre-β HDL. No change was observed in aqueous diffusion nor in the ABCG1-mediated CEC. Serum CLC was significantly reduced (-13.3%; p = 0.026). Levels of adiponectin were increased (+50.6%; p < 0.0001) and resistin levels were decreased (-24.3%; p < 0.0001). After vitD replacement, an inverse relationship was found linking the ABCA1-mediated CEC with pre-β HDL (r
2 = 0.346; p < 0.001) and resistin (r2 = 0.220; p = 0.009)., Conclusion: Our data support vitD supplementation for CV risk prevention., (Copyright © 2018 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.)- Published
- 2018
- Full Text
- View/download PDF
33. Aerobiological monitoring and mapping of Ambrosia plants in the province of Parma (northern Italy, southern Po valley), a useful tool for targeted preventive measures.
- Author
-
Albertini R, Ugolotti M, Ghillani L, Adorni M, Vitali P, Signorelli C, and Pasquarella C
- Subjects
- Italy, Seasons, Time Factors, Air Pollutants, Ambrosia, Environmental Monitoring, Pollen, Rhinitis, Allergic, Seasonal prevention & control
- Abstract
Background: Ambrosia is an annual anemophilous weed producing allergenic pollen affecting public health in European countries. In Italy, the most infested region is Lombardy where, in some areas, it is the major cause of hay fever. In the Parma district, until 2007, Ambrosia seemed to be very rare, despite an observed increase of Seasonal Pollen Index (SPI), of pollen peak value and of asthma among ragweed sensitized patients. The aims of this study were to calculate ragweed pollen season and trends from 1996 to 2015, to assess the relationships between pollen season characteristics and selected meteorological data, to map plants in the territory and to evaluate the presence of beetle Ophraella communa (Ophraella), known as an eater of Ambrosia leaves., Methods: The following pollination parameters: start, end, duration, peak concentration date, peak values, SPI and the following climatic parameters: temperature, relative humidity, rainfall, were analyzed. The ragweed plants sites were mapped and the presence of Ophraella was assessed during naturalistic activities., Results: Significant SPI and pollen peak value increase until 2011 were observed, but recently, 2012-2015 vs 2009-2011, a strong reduction (about 50%) of these parameters was observed. The spring average air temperature increased significantly. The results of the correlation analysis showed Ambrosia season characteristics significantly related. We identified the sites source of Ambrosia, even downtown at the confluence between Parma and Baganza rivers. Ophraella was observed for the first time in 2014., Conclusions: The results showed the spread of ragweed plants over the territory and the risk of allergy increase that ragweed could cause. It remains to evaluate the role of the Ophraella in the reduction of Ambrosia pollen concentration. It is important to consider the potential risk Ophraella may represent for sunflower and other taxonomically related crop plants and other native and exotic species. The lack of initiatives by the Health Authorities to prevent and to contrast the spread of Ambrosia in the Parma area could cause public health consequences and an increase in health expenditures.
- Published
- 2017
- Full Text
- View/download PDF
34. Incorporating 3D laparoscopy for the management of locally advanced cervical cancer: a comparison with open surgery.
- Author
-
Raspagliesi F, Bogani G, Martinelli F, Signorelli M, Chiappa V, Scaffa C, Sabatucci I, Adorni M, Lorusso D, and Ditto A
- Subjects
- Combined Modality Therapy, Female, Humans, Intraoperative Complications, Neoplasm Grading, Neoplasm Staging, Organ Sparing Treatments, Postoperative Complications, Prospective Studies, Treatment Outcome, Uterine Cervical Neoplasms therapy, Hysterectomy methods, Laparoscopy methods, Surgery, Computer-Assisted methods, Uterine Cervical Neoplasms pathology, Uterine Cervical Neoplasms surgery
- Abstract
Purpose: To test the effects of the implementation of 3D laparoscopic technology for the execution of nerve-sparing radical hysterectomy., Methods: Thirty patients undergoing nerve-sparing radical hysterectomy via 3D laparoscopic (3D-LNSRH, n = 10) or open surgery (NSRH, n = 20) were studied prospectively., Results: No significant differences were observed in baseline patient characteristics. Operative times were similar between groups. We compared the first 10 patients undergoing 3D-LNSRH with the last 20 patients undergoing NSRH. Baseline characteristics were similar between groups (p>0.2). Patients undergoing 3D-LNSRH had longer operative time (264.4 ± 21.5 vs 217.2 ± 41.0 minutes; p = 0.005), lower blood loss (53.4 ± 26.1 vs 177.7 ± 96.0 mL; p<0.001), and shorter length of hospital stay (4.3 ± 1.2 vs 5.4 ± 0.7 days; p = 0.03) in comparison to patients undergoing open abdominal procedures. No intraoperative complication occurred. One (10%) patient had conversion to open surgery due to technical difficulties and the inability to insert the uterine manipulator. A trend towards higher complication (grade 2 or worse) rate was observed for patients undergoing NSRH in comparison to 3D-LNSRH (p = 0.06). Considering only severe complications (grade 3 or worse), no difference was observed (0/10 vs 2/20; p = 0.54)., Conclusions: 3D-laparoscopic nerve-sparing radical hysterectomy is a safe and effective procedure. The implementation of 3D laparoscopic technology allows the execution of challenging operations via minimally invasive surgery, thus reducing open abdominal procedure rates. Further large prospective studies are warranted.
- Published
- 2016
- Full Text
- View/download PDF
35. Lomitapide affects HDL composition and function.
- Author
-
Yahya R, Favari E, Calabresi L, Verhoeven AJM, Zimetti F, Adorni MP, Gomaraschi M, Averna M, Cefalù AB, Bernini F, Sijbrands EJG, Mulder MT, and Roeters van Lennep JE
- Subjects
- Adult, Atherosclerosis, Cholesterol metabolism, Cholesterol, HDL blood, Cholesterol, LDL blood, Female, Homozygote, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors therapeutic use, Hyperlipoproteinemia Type II blood, Hyperlipoproteinemia Type II genetics, Male, Phenotype, Treatment Outcome, Young Adult, ATP Binding Cassette Transporter 1 genetics, Benzimidazoles pharmacology, Lipoproteins, HDL blood, Lipoproteins, HDL drug effects
- Abstract
Background: Lomitapide reduces low-density lipoprotein-cholesterol (LDL-C) but also high-density lipoprotein-cholesterol (HDL-C) levels. The latter may reduce the clinical efficacy of lomitapide. We investigated the effect of lomitapide on HDL-C levels and on cholesterol efflux capacity (CEC) of HDL in patients with homozygous familial hypercholesterolemia (HoFH)., Methods and Results: Four HoFH patients were treated with increasing dosages of lomitapide. Lomitapide decreased LDL-C (range -34 to -89%). Total HDL-C levels decreased (range -16 to -34%) with a shift to buoyant HDL. ABCA1-mediated CEC decreased in all patients (range -39 to -99%). The changes of total, ABCG1- and SR-BI-mediated CEC were less consistent., Conclusion: Lomitapide decreased LDL-C and HDL-C levels. Our report raises the hypothesis that the anti-atherogenic potential of HDL seems to be unaffected as total CEC did not seem to change consistently. Combined with the reduction of atherogenic lipoproteins, the net effect of lomitapide appears to be beneficial in HoFH patients., (Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
36. The natural compound berberine positively affects macrophage functions involved in atherogenesis.
- Author
-
Zimetti F, Adorni MP, Ronda N, Gatti R, Bernini F, and Favari E
- Subjects
- Animals, Anticholesteremic Agents pharmacology, Cell Membrane chemistry, Cell Membrane drug effects, Cells, Cultured, Chemokine CCL2 blood, Chemokine CCL2 metabolism, Cholesterol chemistry, Humans, Hypercholesterolemia blood, Macrophages metabolism, Mice, Mice, Inbred C57BL, Atherosclerosis drug therapy, Berberine pharmacology, Macrophages drug effects
- Abstract
Background and Aims: We investigated the effect of berberine (BBR), an alkaloid showing antiatherogenic properties beyond the cholesterol lowering capacity, on macrophage cholesterol handling upon exposure to human serum and on macrophage responses to excess free cholesterol (FC) loading., Methods and Results: Mouse and human macrophages were utilized as cellular models. Cholesterol content was measured by a fluorimetric assay; cholesterol efflux, cytotoxicity and membrane FC distribution were evaluated by radioisotopic assays. Monocyte chemotactic protein-1 (MCP-1) secretion was measured by ELISA; membrane ruffling and macropinocytosis were visualized by confocal microscopy. Exposure of cholesterol-enriched MPM to serum in the presence of 1 μM BBR resulted in a reduction of intracellular cholesterol content twice greater than exposure to serum alone (-52%; p < 0.01 and -21%; p < 0.05), an effect not mediated by an increase of cholesterol efflux, but rather by the inhibition of cholesterol uptake from serum. Consistently, BBR inhibited in a dose-dependent manner cholesterol accumulation in human macrophages exposed to hypercholesterolemic serum. Confocal microscope analysis revealed that BBR inhibited macropinocytosis, an independent-receptor process involved in LDL internalization. Macrophage FC-enrichment increased MCP-1 release by 1.5 folds, increased cytotoxicity by 2 fold, and induced membrane ruffling; all these responses were markedly inhibited by BBR. FC-enrichment led to an increase in plasma membrane cholesterol by 4.5 folds, an effect counteracted by BBR., Conclusion: We showed novel potentially atheroprotective activities of BBR in macrophages, consisting in the inhibition of serum-induced cholesterol accumulation, occurring at least in part through an impairment of macropinocytosis, and of FC-induced deleterious effects., (Copyright © 2014 Elsevier B.V. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
37. Cellular cholesterol efflux and cholesterol loading capacity of serum: effects of LDL-apheresis.
- Author
-
Adorni MP, Zimetti F, Puntoni M, Bigazzi F, Sbrana F, Minichilli F, Bernini F, Ronda N, Favari E, and Sampietro T
- Subjects
- ATP Binding Cassette Transporter 1, ATP Binding Cassette Transporter, Subfamily G, Member 1, ATP-Binding Cassette Transporters metabolism, Biological Transport, CD36 Antigens metabolism, Diffusion, Female, Humans, Hyperlipoproteinemia Type II blood, Hyperlipoproteinemia Type II therapy, Macrophages metabolism, Male, Middle Aged, Time Factors, Water metabolism, Blood Component Removal, Cholesterol, LDL blood, Cholesterol, LDL metabolism
- Abstract
High LDL-cholesterol (LDL-C) characterizes familial hypercholesterolemia (FH) and familial combined hyperlipidemia (FCH). LDL-apheresis, used in these patients to reduce LDL-C levels, has been shown to also affect HDL levels and composition. We studied LDL-apheresis effects on six FH and nine FCH subjects' serum capacity to modulate cellular cholesterol efflux, an index of HDL functionality, and to load macrophages with cholesterol. Serum cholesterol efflux capacity (CEC) and macrophage cholesterol loading capacity (CLC) were measured before, immediately after, and two days after LDL-apheresis. The procedure reduced total cholesterol (TC), LDL-C, and apoB plasma levels (-69%, -80% and -74%, respectively), parameters only partially restored two days later. HDL-C and apoA-I plasma levels, reduced after LDL-apheresis (-27% and -16%, respectively), were restored to almost normal levels two days later. LDL-apheresis reduced serum aqueous diffusion (AD) CEC, SR-BI-CEC, and ABCA1-CEC. AD and SR-BI were fully restored whereas ABCA1-CEC remained low two days later. Sera immediately and two days after LDL-apheresis had a lower CLC than pre-LDL-apheresis sera. In conclusion, LDL-apheresis transiently reduces HDL-C levels and serum CEC, but it also reduces also serum capacity to deliver cholesterol to macrophages. Despite a potentially negative effect on HDL levels and composition, LDL-apheresis may counteract foam cells formation.
- Published
- 2012
- Full Text
- View/download PDF
38. [Effect of xylamide against some effects elicited by caerulein].
- Author
-
Mantovani P, Piccinin GL, and Adorni MC
- Subjects
- Animals, Blood Pressure drug effects, Dogs, Gallbladder drug effects, Gastric Juice drug effects, Glutamates pharmacology, Guinea Pigs, Muscle Contraction drug effects, Muscle, Smooth drug effects, Peptides pharmacology, Pylorus drug effects, Rats, Gastric Juice metabolism, Pancreatic Juice drug effects
- Published
- 1971
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.